Healwell AI Inc. (AIDX.TO)
| Previous Close | 1.3200 |
| Open | 1.3500 |
| Bid | 1.5100 x N/A |
| Ask | 1.5400 x N/A |
| Day's Range | 1.3300 - 1.5400 |
| 52 Week Range | 0.6500 - 3.2600 |
| Volume | |
| Avg. Volume | 364,830 |
| Market Cap | 252.369M |
| Beta (5Y Monthly) | -1.12 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2500 |
| Earnings Date | Nov 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.69 |
NewsfileHEALWELL Provides Corporate Update on Accelerating Commercialization and Expansion of Pharmaceutical Partnerships by Leveraging Its Best-in-Class Patient Identification Capabilities
HEALWELL's AI and data science subsidiaries have executed 5 new Master Services Agreements ("MSA") with new pharmaceutical partners in Q3-2024; bringing the total number of MSAs with life sciences partners to 27, which includes 6 of the top 10 pharmaceutical companies in the world. HEALWELL's AI and data science subsidiaries generated patient identification revenue from 23 of these pharmaceutical partners in Q3-2024.HEALWELL subsidiary, Khure Health, has executed an MSA for patient identificatio
NewsfileHEALWELL AI to Announce Third Quarter 2024 Financial Results on November 12, 2024
HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, November 12, 2024, at 1:00 pm EST (10:00 am PST).Toronto, Ontario--(Newsfile Corp. - November 4, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce the Company will release its Fiscal Third Quarter 2024 financial results for the period ended September ...
